Drug Pipeline

RO7795081 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
1
Top Sponsors
Active Studies by Phase
Phase 2
2
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07112872 A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People… Type 2 Diabetes Mellitus Active, Not Recruiting
NCT07081958 A Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or… Obesity or Overweight Active, Not Recruiting
Phase 1
NCT06982131 A Study Investigating the Safety of RO7795081 and the Effect of RO7795081 on How the Body… Overweight Recruiting
NCT07499050 A Study of Multiple Doses of Orally Administered RO7795081 in Otherwise Healthy Chinese… Healthy Volunteers Recruiting
Sponsors Running RO7795081 Trials
Disease Areas
Get alerts when RO7795081 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free